Joint publication that Unitaid has released with the World Health Organisation and the Clinton Health Access Initiative featuring TruScreen as the only Electro-optical Cervical Cancer…
TruScreen announces that it has now commenced the large scale Chinese evaluation (previously advised) with The Women’s and Children’s Division of the Centre for Disease…
TruScreen Limited announces that its newly commissioned facility to manufacture the diagnostic Opto-electric front-end component of its device in Australia is now fully operational.
Highlights Include: TruScreen’s first-quarter sales to 30 June 2018, surpass total sales in the previous financial year. Increased interest and uptake of TruScreen in China
TruScreen has released its preliminary results for the year ended 31 March 2018 and is forecasting a significant uplift in sales for the new financial…
